Voting
Your vote is IMPORTANT!
Please vote your proxy online now or by phone by dialing 866-506-2806.
View an enhanced version of our Annual Report.
View an enhanced version of our Notice of Meeting & Proxy Statement.
Your vote is IMPORTANT!
Please vote your proxy online now or by phone by dialing 866-506-2806.
June 5, 2026
9:00 AM ET
You must register to attend the meeting.
Registration Deadline: June 4, 2026 11:59 PM Eastern Time
Climb Bio, Inc. is a clinical-stage biotechnology company with a mission to deliver high impact, disease-modifying medicines for individuals living with immune-mediated diseases, including those affecting kidney health. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has potential to treat a broad range of B-cell mediated diseases, and CLYM116, an anti-APRIL monoclonal antibody being developed for IgA nephropathy.